US Broker Ratings

Mettler-Toledo International, Inc. (MTD): Analyst Ratings Signal Potential 17.46% Upside for Investors

Mettler-Toledo International, Inc. (NYSE: MTD), a Swiss-based leader in precision instruments, stands as a compelling entity within the Diagnostics & Research industry of the Healthcare sector...

Becton, Dickinson and Company (BDX): Analyst Ratings and 28% Potential Upside Signal Opportunity

For investors eyeing the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) stands out as a significant player, boasting a market capitalization of $42.47 billion. Known..

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Navigating a 32% Potential Upside Amid Industry Leadership

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, is captivating investor attention with its robust market presence and a promising potential upside..

GSK plc (GSK) Stock Analysis: Navigating a Potential 11.71% Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a leading player in the healthcare sector, continues to capture investor interest with its robust portfolio of vaccines and specialty medicines. With..

Haleon plc (HLN) Stock Analysis: Unlocking a 25% Potential Upside in the Healthcare Sector

Haleon plc (NYSE: HLN), a formidable player in the healthcare sector, commands investor attention with its robust portfolio of consumer healthcare products. With a market cap..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 54% Potential Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a powerhouse in health information services, is capturing investor attention with its robust market presence and a remarkable potential upside of..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 15.67% Potential Upside in the Healthcare Giant

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the healthcare sector, with a robust market capitalization of $277.02 billion. Known for its..

Pfizer, Inc. (PFE) Investor Outlook: Evaluating a 10.15% Potential Upside Amidst Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a stalwart in the healthcare sector, with a market capitalization of $149.77 billion. As a major player in the drug..

Novo Nordisk A/S (NVO): Investor Outlook Reveals 6.24% Potential Upside

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, has long been synonymous with groundbreaking advancements in the pharmaceutical industry. With a robust market..

Zoetis Inc. (ZTS) Stock Analysis: Robust Growth Potential with a 30% Upside

For investors seeking exposure in the healthcare sector, Zoetis Inc. (NYSE: ZTS) presents a compelling opportunity with its strong market position in the animal health industry...

Amgen Inc. (AMGN) Stock Analysis: Exploring a 7.16% Upside Potential Amidst Robust Revenue Growth

Amgen Inc. (NASDAQ: AMGN), a global leader in biotechnology, is captivating investors with a compelling narrative of steady growth, robust revenue figures, and a promising upside..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 50.77% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, is currently presenting an intriguing opportunity for investors. With a market..

Prestige Consumer Healthcare (PBH) Stock Analysis: Unpacking a 33% Potential Upside for Investors

Prestige Consumer Healthcare Inc. (PBH) stands as a notable entity within the healthcare sector, specifically in the arena of specialty and generic drug manufacturing. With a..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a Promising 36% Upside with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning name in the biotechnology sector, is capturing attention with its ambitious plans to revolutionize cancer treatment. With a current market..

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 43% Potential Upside Amidst Strong Analyst Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI) is currently catching the attention of savvy investors, given its notable position within the healthcare sector and impressive potential for..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating Biotech Volatility with Strategic Growth Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, has been capturing the attention of investors with its focus on RNA-targeted therapeutics and..

Ionis Pharmaceuticals, Inc. (IONS): Analyst Consensus Highlights 34.76% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands at a pivotal moment for investors seeking opportunities in the healthcare sector. As a biotechnology stalwart based in Carlsbad, California,..

AptarGroup, Inc. (ATR) Stock Analysis: Unveiling a 31% Potential Upside for Investors

AptarGroup, Inc. (NYSE: ATR) stands out as a compelling investment opportunity within the healthcare sector, particularly in the niche of medical instruments and supplies. With a..

Telix Pharmaceuticals Limited (TLX): Investor Outlook on a Promising 105% Upside

Telix Pharmaceuticals Limited (ASX: TLX) stands at an intriguing juncture with significant potential upside, making it a compelling consideration for investors in the biotechnology sector. This..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Evaluating a 15.97% Upside Potential in Eye Health Innovation

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector specializing in medical instruments and supplies, is gaining attention from individual investors due to..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds